You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb1734969 |
|---|---|
| Category | Small Molecules |
| Description | 5-VdU (5-Vinyl-2'-deoxyuridine) can be used as a replacement for BrdU (5-Bromo-2'-deoxyuridine) or the copper-catalyst requiring 5-EdU (5-Ethynyl-2'-deoxyuridine) to measure de novo DNA synthesis during the S-phase of the cell cycle. 5-VdU is cell permeable and incorporates into replicating DNA instead of its natural analog thymidine. The resulting vinyl-functionalized DNA can subsequently be detected via Cu(I)-free Alkene-Tetrazine Ligation that offers the choice to introduce a Biotin group (via Tetrazines of Biotin) for subsequent purification tasks or a fluorescent group (via Tetrazines of fluorescent dyes) for subsequent microscopic imaging. |
| Form/Appearance | solid; Color: white to off-white |
| Purity | ≥ 98% (HPLC) |
| MW | Theoretical MW: 254.24 g/mol; Detected MW: 254.09 g/mol |
| Application notes | DNA synthesis monitoring. Spectroscopic Propertie: λmax 292 nm, ε 9.2 L mmol-1 cm-1, (Methanol). |
| Solubility (25°C) | DMSO, methanol |
| CAS Number | 55520-67-7 |
| Formula | C11H14N2O5 |
| SMILES | n1(cc(c(=O)[nH]c1=O)C=C)[C@H]1C[C@@H]([C@H](O1)CO)O |
| Storage | store at -20 °C. Short term exposure (up to 1 week cumulative) to ambient temperature possible |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
≥ 98% (HPLC) | |
55520-67-7 | |
Theoretical MW: 254.24 g/mol; Detected MW: 254.09 g/mol | |
C11H14N2O5 |
≥ 98% (HPLC) | |
55520-64-4 | |
Theoretical MW: 270.24 g/mol; Detected MW: 270.09 g/mol | |
C11H14N2O6 |
≥ 98% (HPLC) | |
55520-64-4 | |
Theoretical MW: 270.24 g/mol; Detected MW: 270.09 g/mol | |
C11H14N2O6 |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review(Recommended: An additional animal making an allowance for loss during the experiment)
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)